Medicinal product name Havrix 1440 ELISA units/ml suspension for injection
Pharmaceutical form Suspension for injection
Strength 1440 ELISA U/ml 
Information from the MAH on shortages Not available
predicted availability date: Jun 30, 2024
Legal status Rx Prescription (Pr.)
Package leafletPDF 23-11-2023
Summary of product characteristicsPDF 23-11-2023
ATC code J07BC02 Vaccines
Information for Marketing authorisation holdersView

Medicinal products (2)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers)
predicted availability date: Jun 30, 2024
currently no information on availability from any wholesaler N1
(1 ml)
Glass pre-filled syringe with 1 needle 35.57  02-0026-03 Labelling text Labelling text Nov 23, 2023
Labelling text Labelling text Nov 23, 2023
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(1 ml)
Glass pre-filled syringe    02-0026-04 Labelling text Labelling text Nov 23, 2023
Labelling text Labelling text Nov 23, 2023

Registration information

Marketing authorisation No. 02-0026
Date of authorisation Jan 16, 2002
Marketing authorisation holder, country GlaxoSmithKline Biologicals S.A., Belgium